AlphaValue downgrades Sandoz stock before October 27 sales update

Published on 10/23/2026 at 10:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AlphaValue cut Sandoz to Reduce on October 19, 2026. Sandoz stock costs EUR 86.11 at Lang & Schwarz on October 23, 2026 before October 27 sales.

Analyst revision and sales date

AlphaValue downgraded Sandoz to Reduce on October 19, 2026.
First-half 2026 sales rose 5.00 percent and the core EBITDA margin reached 20.90 percent.
Sandoz stock trades at EUR 86.11 at 10:13 a.m. CEST at Lang & Schwarz on October 23, 2026.
The next sales update is scheduled for October 27, 2026.

Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz stock (ISIN CH1243598427) was trading at EUR 86.11 at Lang & Schwarz on October 23, 2026 at 10:13 a.m. CEST. MarketScreener reported that AlphaValue/Baader Europe downgraded Sandoz to Reduce on October 19, 2026. The next sales update is scheduled for October 27, 2026.

The next test is sales growth

The October 27 update will test whether Sandoz can extend the operating progress shown in its first-half 2026 results. First-half sales increased 5.00 percent to USD 5.78 billion, according to the company's earnings-call transcript carried by Yahoo Finance.

Biosimilars accounted for 33.00 percent of first-half sales, while the core EBITDA margin expanded by 90 basis points to 20.90 percent. That combination gives the sales update two tests: demand growth and evidence that the margin can hold as the product mix changes.

What does the margin mean?

Cash reported that Oddo raised its Sandoz target to CHF 75.00 from CHF 62.00 while keeping a Neutral rating. The same report said Goldman Sachs raised its target from CHF 80.00 to CHF 85.00 and Morgan Stanley lifted its target from CHF 55.00 to CHF 60.00.

Three dated signals frame the setup

On September 29, 2026, Sandoz opened its high-volume biosimilar drug-substance facility in Lendava, Slovenia, a project staffed by more than 300 experts, according to Simply Wall St. On October 6, 2026, Morgan Stanley raised its target to CHF 60.00 from CHF 55.00. AlphaValue's October 19 downgrade is the latest of the three signals.

The next company date

The October 27, 2026 sales release is the next scheduled company event. For investors, the useful read-through will be whether reported growth confirms the 5.00 percent first-half increase while biosimilars remain a material share of sales.

Price and listing context

The primary Swiss listing was quoted at CHF 79.22 at 10:09 a.m. UTC on October 23, 2026, equivalent to 12:09 p.m. CEST, with a market capitalization of CHF 34.3 billion. The 52-week range was CHF 47.73 to CHF 79.40. Sandoz was therefore trading near the upper end of its Swiss range while the euro quotation stood at EUR 86.11.

The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.